Xiaobin Luo1,2,3, Zhenwei Pan4, Hongli Shan4, Jiening Xiao3, Xuelin Sun4, Ning Wang1, Huixian Lin3, Ling Xiao2,5,3, Ange Maguy3, Xiaoyan Qi3, Yue Li6, Xu Gao7, De‐Li Dong4, Yong Zhang4, Yunlong Bai1, Jing Ai8,9, Lihua Sun4, Hang Lu1,4, Xiaoyan Luo3, Zhiguo Wang1,4, Yanjie Lu1,4, Baofeng Yang1,4, Stanley Nattel2,5,3
1Cardiovascular Research Institute (Key Laboratory of Cardiovascular Research, Ministry of Education of China)
2Department of Medicine, Université de Montréal, Montreal, Quebec, Canada
3Research Center, Montreal Heart Institute, Montreal, Quebec, Canada
4Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), Harbin Medical University, Harbin, People’s Republic of China
5Department of Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada
6First Affiliated Hospital and
7Department of Biochemistry, Harbin Medical University, Harbin, People's Republic of China.
85000 Belanger St., Montreal, PQ H1T 1C8, Canada.
9Harbin Medical University, Harbin, Heilongjiang 150086, China.